The Use of Indomethacin for Nocturnal Enuresis in Children With Nephrogenic Diabetes Insipidus: A Case Report and Review of the Literature
Open Access
- 26 July 2022
- journal article
- review article
- Published by SAGE Publications in Canadian Journal of Kidney Health and Disease
- Vol. 9
Abstract
Rationale: Nocturnal enuresis is a common symptom of nephrogenic diabetes insipidus (NDI) in children. Published reports on the treatment of nocturnal enuresis in this population are scarce. Presenting concern of the patient: 2 brothers, aged 8 and 9 years, presented for outpatient pediatric nephrology follow-up. Despite being medically stable on their current medication regimen, they both experienced significant distress due to primary nocturnal enuresis, including decreased self-esteem and social stress. Diagnoses: The brothers had primary nocturnal enuresis related to their high urine output from NDI. Interventions: we describe a case of 2 brothers with NDI in whom indomethacin was added to their pharmacologic treatment specifically to address enuresis. Outcome: Both brothers experienced a significant decrease in the frequency of nocturnal enuresis and improvement in their perceived quality of life. Teaching points: Nocturnal enuresis is a bothersome symptom of NDI with adverse psychological effects. Indomethacin can improve nocturnal enuresis in some patients. Treatment with nonsteroidal anti-inflammatory drugs carries a risk of gastrointestinal and kidney side effects. We advocate for a patient-centered approach to the treatment of NDI which includes optimizing both the medical and the psychological needs of the patient.Keywords
This publication has 21 references indexed in Scilit:
- Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studiesEuropean Journal of Internal Medicine, 2015
- Mono-Symptomatic Nocturnal Enuresis in Lebanese Children: Prevalence, Relation with Obesity, and Psychological EffectClinical Medicine Insights: Pediatrics, 2014
- Self‐esteem in 6‐ to 16‐year‐olds with monosymptomatic nocturnal enuresisJournal of Paediatrics and Child Health, 2012
- Congenital nephrogenic diabetes insipidus: the current state of affairsPediatric Nephrology, 2012
- Nonsteroidal Anti-Inflammatory Drugs and the KidneyPharmaceuticals, 2010
- Precision and sensitivity of the short-form pediatric enuresis module to assess quality of life (PEMQOL)Journal of Pediatric Urology, 2007
- Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia EventsJAMA, 2006
- Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidusPediatric Nephrology, 2005
- The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic reviewBMJ, 2004
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000